Published in J Infect Dis on February 03, 2015
HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection. Papillomavirus Res (2016) 0.75
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol (1998) 9.43
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet (2011) 4.70
The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev (2008) 3.93
Prevalence and stability of sexual orientation components during adolescence and young adulthood. Arch Sex Behav (2006) 2.63
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health (2010) 2.14
Correlates of homosexual behavior and the incidence of anal cancer. JAMA (1982) 1.95
Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis (2008) 1.93
Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis (2011) 1.84
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer (2012) 1.66
Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis (2013) 1.33
The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study. Sex Transm Dis (2011) 1.24
Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis (2005) 1.17
An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer (2009) 1.14
Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.04
Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men. Cancer Epidemiol Biomarkers Prev (2012) 0.95
Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. PLoS One (2013) 0.95
Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. Sex Transm Dis (2009) 0.95
Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix. Eur J Gynaecol Oncol (2007) 0.92
Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011. Sex Transm Dis (2014) 0.89
Prevalence, clearance, and incidence of human papillomavirus type-specific infection at the anal and penile site of HIV-infected men. Sex Transm Dis (2013) 0.87
The burden of hospitalizations for anus and penis neoplasm in Spain (1997-2008). Hum Vaccin Immunother (2012) 0.81
Persistence and clearance of HPV from the penis of men infected and non-infected with HIV. J Med Virol (2011) 0.78
Seroconversion Following Anal and Genital HPV Infection in Men: The HIM Study. Papillomavirus Res (2015) 0.89
Human Papillomavirus Prevalence Among 88 Male Virgins Residing in Brazil, Mexico, and the United States. J Infect Dis (2016) 0.78
Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study. Cancer Res (2016) 0.75